Answer
Shake Cell-based Trivalent Influenza Vaccine Seqirus before use to obtain a clear to slightly opalescent suspension, then visually inspect for particulate matter and discoloration before administration; do not administer if foreign particulate matter or any variation in physical appearance is observed.
Sources for this answer
- Cell-based Trivalent Influenza Vaccine SeqirusSeqirus UK Limited · emc · SmPC §6.6 Special precautions for disposal and other handling · Version 4Document updated
Sources checked